BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 19074986)

  • 1. Expansion of human regulatory T-cells from patients with type 1 diabetes.
    Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
    Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD4
    Brown ME; Peters LD; Hanbali SR; Arnoletti JM; Sachs LK; Nguyen KQ; Carpenter EB; Seay HR; Fuhrman CA; Posgai AL; Shapiro MR; Brusko TM
    Front Immunol; 2022; 13():873560. PubMed ID: 35693814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
    Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
    Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.
    McClymont SA; Putnam AL; Lee MR; Esensten JH; Liu W; Hulme MA; Hoffmüller U; Baron U; Olek S; Bluestone JA; Brusko TM
    J Immunol; 2011 Apr; 186(7):3918-26. PubMed ID: 21368230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal cells recruit and regulate T regulatory cells.
    Di Ianni M; Del Papa B; De Ioanni M; Moretti L; Bonifacio E; Cecchini D; Sportoletti P; Falzetti F; Tabilio A
    Exp Hematol; 2008 Mar; 36(3):309-18. PubMed ID: 18279718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified flow cytometry method for objective estimation of human CD4
    Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
    Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
    Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE
    Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis patients have reduced resting and increased activated CD4
    Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ
    Sci Rep; 2021 May; 11(1):10476. PubMed ID: 34006899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells.
    Mittag D; Scholzen A; Varese N; Baxter L; Paukovics G; Harrison LC; Rolland JM; O'Hehir RE
    J Immunol; 2010 May; 184(9):4708-16. PubMed ID: 20308632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.
    Battaglia M; Stabilini A; Migliavacca B; Horejs-Hoeck J; Kaupper T; Roncarolo MG
    J Immunol; 2006 Dec; 177(12):8338-47. PubMed ID: 17142730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of culture medium on CD4(+) CD25(high)CD127(lo/neg) Treg expansion for the purpose of clinical application.
    Gołąb K; Krzystyniak A; Marek-Trzonkowska N; Misawa R; Wang LJ; Wang X; Cochet O; Tibudan M; Langa P; Millis JM; Trzonkowski P; Witkowski P
    Int Immunopharmacol; 2013 Jul; 16(3):358-63. PubMed ID: 23466550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
    Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
    Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
    Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
    Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans.
    Vukmanovic-Stejic M; Sandhu D; Sobande TO; Agius E; Lacy KE; Riddell N; Montez S; Dintwe OB; Scriba TJ; Breuer J; Nikolich-Zugich J; Ogg G; Rustin MH; Akbar AN
    J Immunol; 2013 Feb; 190(3):977-86. PubMed ID: 23284056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.